Kymera Therapeutics
KYMR
KYMR
136 hedge funds and large institutions have $1.55B invested in Kymera Therapeutics in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 36 increasing their positions, 53 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
12% more funds holding
Funds holding: 121 → 136 (+15)
6.24% more ownership
Funds ownership: 103.5% → 109.74% (+6.2%)
32% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 53
Holders
136
Holding in Top 10
6
Calls
$1.97M
Puts
$433K
Top Buyers
| 1 | +$31.7M | |
| 2 | +$18.5M | |
| 3 | +$13.8M | |
| 4 |
Goldman Sachs
New York
|
+$12M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$11.1M |
Top Sellers
| 1 | -$8.55M | |
| 2 | -$8.01M | |
| 3 | -$7.96M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$5.39M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$3.69M |